Combined intravitreal bevacizumab and photodynamic therapy with vertiporfin for management of choroidal neovascularization secondary to age-related macular degeneration

PURPOSE: To test the results for patients treated with combined photodynamic therapy (PDT) with vertiporfin (Visudyne, Novartis AG) and intravitreal bevacizumab for choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD). PATIENTS AND METHODS: This is a prospective stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kabeel, Mamdouh M, El-Batarny, Ashraf M, Tameesh, Mohamed K, Abou El Enein, Moustafa A
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2698683/
https://www.ncbi.nlm.nih.gov/pubmed/19668400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2698683/
https://www.ncbi.nlm.nih.gov/pubmed/19668400

Ejemplares similares